A Randomized, Open-label, Multiple-dose, Two-arm, One-sequence • Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration Telmisartan/S-amlodipine and Rosuvastatin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Rosuvastatin
- Indications Hypertension
- Focus Pharmacokinetics
- Acronyms CKD-346 DDI P1
- Sponsors Chong Kun Dang
- 18 Jun 2014 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea - KCT0001086 ).
- 16 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Feb 2014 New trial record